HomeNURL • CNSX
add
Neural Therapeutics Inc
Previous close
$0.035
Day range
$0.035 - $0.045
Year range
$0.020 - $0.050
Market cap
3.10M CAD
Avg Volume
85.16K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 119.26K | -31.81% |
Net income | -115.84K | 34.36% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 546.32K | 678.41% |
Total assets | 558.70K | 535.52% |
Total liabilities | 997.40K | 95.61% |
Total equity | -438.71K | — |
Shares outstanding | 88.70M | — |
Price to book | -3.50 | — |
Return on assets | -90.89% | — |
Return on capital | 533.20% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -115.84K | 34.36% |
Cash from operations | -7.46K | -193.00% |
Cash from investing | — | — |
Cash from financing | 461.74K | 585.11% |
Net change in cash | 454.28K | 621.19% |
Free cash flow | -165.53K | -413.62% |
About
Founded
2020
Website
